Legendary Dr. Hagop Kantarjian Receives Karnofsky Award for Transforming Care in Leukemia

Legendary Dr. Hagop Kantarjian Receives Karnofsky Award for Transforming Care in Leukemia

Hagop Kantarjian, MD, of The University of Texas MD Anderson Cancer Center (MD Anderson), will receive the 2023 David A. Karnofsky Memorial Award for his contributions to the development of novel therapies for several types of leukemia, and his dedication to improving the lives of patients with cancer.

The David Karnofsky Memorial Award “is the Society’s highest scientific honor, and I am humbled and deeply honored to be its recipient this year,” said Dr. Kantarjian. He will present a lecture during the ASCO Annual Meeting on June 3.

Dr. Kantarjian is known for his practice-changing translational research accomplishments in leukemia. His work has transformed the standards of care for several subtypes of leukemia and led to significant improvements in the survival of patients with chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and myelodysplastic syndrome (MDS).

Read full at : MD Anderson newsroom